Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global Forecast to 2018

The global molecular biology enzymes, kits and reagents market is segmented by application, end users, products, and geographies. Molecular biology enzymes, kits and reagents find applications in a large number of fields of life science research. The application segments included in this report are cloning, epigenetics, PCR (polymerase chain reaction), restriction digestion, sequencing, and other applications. The end-user segments of this market are academic research institutes, hospitals and diagnostics centers, pharmaceutical and biotech companies, and other end users.

The product segments included in this report are enzymes, and kits & reagents. The enzymes segment is divided into the ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptases, and other enzymes sub-segments. The ligase enzyme sub-segment is further divided into T4 DNA ligase, thermostable DNA ligase, and other ligases. The polymerase enzyme sub-segment is divided into high fidelity DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, and other polymerases, while the restriction endonuclease enzyme sub-segment is divided into BamHI, EcoRI, PstI, and other restriction endonucleases.

The kits and reagents product segment has five sub-segments, namely, cloning and mutagenesis, nucleic acid analysis, PCR sequencing, and other kits and reagents.

The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and U.S. RoW encompasses Latin America, Middle East and Africa, and the Pacific countries.

The key drivers for this market are the rising R&D expenditure by the pharmaceutical and biotech companies, and increasing public funding for life science research. The World Health Organization estimates that the total aged population may rise from 605 million in 2000 (11% of the global population) to 2 billion by 2050, accounting for 22% of the global population. As this segment of the world population is more susceptible to chronic diseases, research into these ailments will become more significant, driving the growth of the molecular biology enzymes, kits & reagents market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global molecular biology enzymes, kits and reagents market and its sub-segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their molecular biology enzymes, kits and reagents market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important sub-segments. It maps market sizes and growth rates of each sub-segment and identifies the segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the molecular biology enzymes, kits and reagents market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
‧ Product Development/Innovation: Product portfolios of top players in the molecular biology enzymes, kits and reagents market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the molecular biology enzymes, kits and reagents market
‧ Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the molecular biology enzymes, kits and reagents market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various molecular biology enzymes, kits and reagents products across geographies
‧ Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the molecular biology enzymes, kits and reagents market

TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKETS COVERED 22
1.3 STAKEHOLDERS 24
1.4 RESEARCH METHODOLOGY 25
1.4.1 SECONDARY RESEARCH 25
1.4.1.1 Key data from secondary sources 26
1.4.2 PRIMARY RESEARCH 27
1.4.2.1 Key data from primary sources 27
1.4.3 MARKET SIZE ESTIMATION METHODOLOGY 28
1.4.4 MARKET FORECAST 29
1.4.5 MARKET DATA VALIDATION AND DATA TRIANGULATION 30
1.5 ASSUMPTIONS 31
2 EXECUTIVE SUMMARY 32
3 MARKET OVERVIEW 37
3.1 INTRODUCTION 38
3.2 MARKET SEGMENTATION 38
3.3 MARKET DYNAMICS 40
3.3.1 MARKET DRIVERS 41
3.3.1.1 Increased funding in life science research to propel the growth of the molecular biology enzymes and kits & reagents market 41
3.3.1.2 Increased intensity of research activities in the pharmaceutical sector to drive the market 41
3.3.1.3 Growth in genomics and molecular diagnostics markets will aid the growth of the molecular biology enzymes and kits & reagents market 42
3.3.1.4 Increased healthcare spending will aid the growth of the molecular biology enzymes and kits & reagents market 42
3.3.1.5 Rapidly aging population and chronic and infectious diseases are expected to drive the molecular biology enzymes and kits & reagents market 43
3.3.2 MARKET RESTRAINTS 43
3.3.2.1 Stringent regulatory framework acts as a major challenge 43
3.3.2.2 High degree of consolidation would act as a high entry barrier for new entrants 44
3.3.3 MARKET OPPORTUNITIES 44
3.3.3.1 Increased use of personalized medicine 44
3.3.3.2 Developing countries present significant opportunities for the molecular biology enzymes and kits & reagents market 44
3.4 MARKET SHARE ANALYSIS 45
4 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION 48
4.1 INTRODUCTION 49
4.2 CLONING 52
4.3 EPIGENETICS 54
4.4 PCR 55
4.5 RESTRICTION DIGESTION 57
4.6 SEQUENCING 58
4.7 OTHER APPLICATIONS 60
5 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER 62
5.1 INTRODUCTION 63
5.2 ACADEMIC RESEARCH INSTITUTES 66
5.3 HOSPITALS AND DIAGNOSTICS CENTERS 68
5.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 69
5.5 OTHER END USERS 71
6 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
6.2 ENZYMES 76
6.2.1 LIGASES 81
6.2.2 PHOSPHATASES 82
6.2.3 POLYMERASES 83
6.2.4 PROTEASES AND PROTEINASES 86
6.2.5 RESTRICTION ENDONUCLEASES 87
6.2.6 REVERSE TRANSCRIPTASES 89
6.2.7 OTHER ENZYMES 91
6.3 KITS & REAGENTS 92
6.3.1 CLONING AND MUTAGENESIS 96
6.3.2 NUCLEIC ACID ANALYSIS 98
6.3.3 PCR 99
6.3.4 SEQUENCING 101
6.3.5 OTHER KITS AND REAGENTS 102
7 GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY GEOGRAPHY 104
7.1 INTRODUCTION 105
7.2 ASIA 108
7.2.1 CHINA 118
7.2.2 INDIA 125
7.2.3 JAPAN 131
7.2.4 REST OF ASIA (ROA) 138
7.3 EUROPE 145
7.3.1 FRANCE 154
7.3.2 GERMANY 160
7.3.3 ITALY 166
7.3.4 SPAIN 172
7.3.5 U.K. 179
7.3.6 REST OF EUROPE (ROE) 185
7.4 NORTH AMERICA 191
7.4.1 CANADA 200
7.4.2 U.S. 206
7.5 REST OF THE WORLD (ROW) 213
7.5.1 LATIN AMERICA 221
7.5.2 MIDDLE EAST AND AFRICA 227
7.5.3 PACIFIC 234
8 COMPETITIVE LANDSCAPE 240
8.1 INTRODUCTION 240
8.2 NEW PRODUCT LAUNCHES 241
8.3 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND JOINT VENTURES 247
8.4 EXPANSIONS 253
8.5 MERGERS AND ACQUISITIONS 255
8.6 OTHER DEVELOPMENTS 256
9 COMPANY PROFILES 259
9.1 AFFYMETRIX, INC. 259
9.2 AGILENT TECHNOLOGIES, INC. 266
9.3 ENZYMATICS, INC. 270
9.4 ILLUMINA, INC. 273
9.5 NEW ENGLAND BIOLABS, INC. 280
9.6 QIAGEN, N.V. 287
9.7 ROCHE, LTD. 291
9.8 SIGMA-ALDRICH CORPORATION 294
9.9 TAKARA BIO, INC. 298
9.10 THERMO FISHER SCIENTIFIC, INC. 303

*Details on Business Overview, Company Snapshot, Product Portfolio, Key Strategy, & Recent Developments might not be captured in case of unlisted companies.